SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-024155
Filing Date
2019-04-09
Accepted
2019-04-09 18:26:08
Documents
2
Period of Report
2019-04-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2189
2 POA DOCUMENT poa.txt EX-24.3_847250 3014
  Complete submission text file 0001209191-19-024155.txt   6567
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Issuer) CIK: 0001117480 (see all company filings)

IRS No.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ENDOCYTE, INC. 3000 KENT AVENUE, SUITE A1-100 WEST LAFAYETTE IN 47906
Business Address
Andriole Michael T. (Reporting) CIK: 0001698751 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35867 | Film No.: 19740315